Effect of dexamethasone in glioblastoma (GBM) patients on systemic and intratumoral T-cell responses induced by personalized neoantigen-targeting vaccine.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.2020
Abstract: 2020Background: The impact of individualized neoepitope vaccination targeting neoantigens arising from tumor-specific mutations for GBM, a low mutation burden tumor with an immunologically cold tum... read more here.
Keywords: glioblastoma gbm; dexamethasone glioblastoma; gbm patients; patients systemic ... See more keywords
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2019.00065
Abstract: Glioblastoma multiforme (GBM) is the most common and malignant of the glial tumors. The world-wide estimates of new cases and deaths annually are remarkable, making GBM a crucial public health issue. Despite the combination of… read more here.
Keywords: dexamethasone glioblastoma; dex; gbm; glioblastoma multiforme ... See more keywords